Research
Awards Grant
(COMPLETED VIA CIP) UAB Center for AIDS Research - UAB CFAR-Community Deep South Treatment Cascade Integration and Enhancement
14th Biennial Congress of the Anaerobe Society of the Americas (ASA)
75N93019F00131 TA02 TO9 Development of a Protocol, Clinical Trial Implementation, Closeout and Analysis of a Phase 2 Clinical Trial to Evaluate the Eficacy of rMenB+OMV NZ (Bexsero, GSK) in Preventing Neisseria Gonorrhoese Infection
75N93019F00132 TA1 TO15 Overall Administrative and Support Activities for the STI CTG to Include Procedures to Identify, Discuss, and Develop Scientific Concepts
A New Paradigm for HIV Treatment: Targeted Degradation of HIV Reverse Transcriptase via the Ubiquitin-Proteasome Pathway
A Novel Source of Mucosal T Cells to Study Immunity in the Female Genital Tract
A Phase 2/3 Open-label, Randomized, Sequential Dose Escalation Cohort Study of T2307 Versus Standard of Care in Treatment of Subjects with Candidemia due to Candida Auris and other Drug-resistant Candida Species: An Adaptive Design Study
A Phase II, Single-Stage, Single Arm Investigation of Oral Valganciclovir Therapy in Infants with Asymptomatic Congenital Cytomegalovirus Infection
A Rational Approach for HIV Vaccine T Cell Epitope Selection
A-Z Clinical Trials Unit
Acquisition of HCMV from Breast Milk-Correlates of Protection
Admin Core: Sexually Transmitted Infections Clinical Trials Group (STI CTG)
Alabama - Clinical Trials Unit
Alabama Clinical Trials Unit (CTU)
Alabama Clinical Trials Unit (CTU)
Alphavirus nsP3 Protein: Roles of Intrinsically Disordered Region in Virus Replication and Pathogenesis
Analysis Of Novel Molecular Mechanisms Regulating Expression Of The Adaptor Protein HSH2 And Class-Switched Antibody Production
Analysis of Variant Epitope Specific CD8 T-Cells to Optimize HIV Vaccine Design
Analysis of the Macrophage Membrane Proteome: Effects of Viral Infection
Animal Models of Infectious Diseases, Part A, A Small Animal Product Screening, Biodefense and Emerging Disease Agents
Antibody Induction by Group B Streptococcal Vaccines for Protection against Fungal Infections
Antiviral Drug Discovery and Development Center (AD3C)
Antiviral Drug Discovery and Development Center - Centers of Excellence for Translational Research
Assessing Flu-Specific Humoral Immunity in Human Lung after Ex Vivo Lung Perfusion
B Cell Intrinsic Interferon-beta Regulates Autoreactive B Cell Development
Bacterial Respiratory Pathogens Reference Laboratory Support
Basic Mechanisms in AIDS Pathogenesis
Biophysical Studies of HIV Assembly and Maturation
Burden of Neonatal Herpes Simplex Virus Infections: Disease Incidence, Adequacy of Diagnostic Assessment, Disease Outcome, and Societal Costs
CD19 Tyrosine-Mediated Signal Transduction In Vivo
CMV Subunit Vaccine in Young Women at Risk
Canonical and Non-Canonical Vitamin D Activation Pathways in Systemic Lupus
Capsule Protects Intracellular Pneumococci during Vascular Endothelial Cell Translocation
Cardiac Microlesion Formation During Invasive Pneumococcal Disease
Cardiac Microlesion Formation during Invasive Pneumococcal Disease
Central and Effector B Cells in the Lung
Chimeric Adenoviruses for an Improved HIV Vaccine
Commensal-Dependent Maturation of the Natural IgM Repertoire
Complement Evasion by Group B Streptococcus
Congenital CMV and CNS Infection Mechanisms of Protective Immunity
Congenital CMV and CNS Infection: Mechanisms of Protective Immunity
Congenital and Perinatal Infections Rare Diseases Clinical Research Consortium (RDCRC)
Contribution of the Effector Treg-B-Antibody Nexus to the Regulation of CNS Autoimmunity
Control of Anti-Viral B Cell Responses by IFNg, T-bet and Eomes
Control of B Cell Differentiation by IFNg Induced Transcription Factors
Control of Chromatin Landscapes in Effector T Cell Lineage Specifications
Controlling Th2 Immunity by Tuning CXCL13 Dependent DC Migration in Lymph Nodes
Copper Transport in Mycobacterium Tuberculosis
Cytomegalovirus Infection Exacerbates Macrophage-driven Inflammation in Inflammatory Bowel Disease
Daily Immune Monitoring in Chronic Fatigue Syndrome
Dectin-1 and Invasive Pulmonary Aspergillosis
Defining the Attachment of Collagen-like Protein BclA to B. Anthracis Spores
Defining the Biological Relevance of HIV Specific HLA-E Restricted CD8 T cell Responses
Defining the Biological Relevance of HIV-1 Adaptation to CD4 T Cell Responses
Defining the Interaction of FCRLA with Immunoglobulin
Depletion of Myeloid-Derived Suppressor Cells (MDSCs) in HIV-1 Infection
Design and Synthesis of Structurally Defined QS-21-Based Synthetic Adjuvants
Determining the Role of NLRP3 on the Placement and Protective Potential of CD73+ BRMs Post Influenza Infection
Development of Structurally Defined QS-17/18-Based Vaccine Adjuvants
Discovery and Preclinical Development of Drugs for Anthrax, Plague and Tularemia
Dual Function of VPO1 in Pathogen Recognition and Killing
Dynamics of the Protective Vaccine-Induced Human Influenza Neuraminidase B Cell Response
Dysbiosis of the Sinus Microbiota in Chronic Rhinosinusitis
Dysbiotic Infections in Chronic Obstructive Pulmonary Disease
Dysregulation of IgA Responses in HIV-1-Infected Individuals
Effects of Neonatal Microbial Exposure on Anti-Polysaccharide B Cell Development
Effects of Neonatal Microbial Exposure on Anti-polysaccharide B Cell Development
Emerging Antiviral Resistance in Congenital Cytomegalovirus Infection
Emerging Macrolide Resistance in Mycoplasma Pneumoniae
Engineering Picoviruses with Defined Host Range to Combat Drug-resistant Staphylococci
Entry of Antigen-Presenting B Cells into the Follicle Directed by IFNa and IL-17
Envelope Assembly of Human Cytomegalovirus
Envelope Assembly of Human Cytomegalovirus
Epigenetic Determinants and Mechanisms Influencing Genital Chlamydia Trachomatis Reinfection in African American Women
Establishment and Metabolic Control of Influenza-Specific Lung-Resident Memory B Cells
Follicular Exclusion of Self Antigens Prevents Development of Autoantibodies
Functional Role of Fc Receptor Homologs on B Lineage Cells
GC Tfh Cell Differentiation
Gene-Engineered Stem Cell Memory T-Cells With Anti-HIV Chimeric Antigen Receptors
Generation and Characterization of Human Cytokine-Producing B Cell Effectors
Genetic Epidemiology of HPV Infection Outcome in Men
Genetically - Engineered Pig Organ Transplantation in Baboons: Immunological and Functional Studies
Genetically-Engineered Pig Organ Transplantation in Baboons: Immunological and Functional Studies - Administrative Core D
Genetically-Engineered Pig Organ Transplantation in Baboons: Immunological and Functional Studies - Genetically-Engineered Pig Kidney Transplantation in Baboons: Reducing the Adaptive Immune Response and Monitoring Graft Function - Project 1
Genetically-Engineered Pig Organ Transplantation in Baboons: Immunological and Functional Studies - Genetically-Engineered Pig Orthotopic (Life-Supporting) Heart Transplantation (OHTx) in Baboons: Establishing Consistent Graft Survival and Overcoming Rapid Post-Tx Organ Growth - Project 3
Genetically-Engineered Pig Organ Transplantation in Baboons: Immunological and Functional Studies - Histopathology Core C
Genetically-Engineered Pig Organ Transplantation in Baboons: Immunological and Functional Studies - Immunobiology Core B
Genetically-Engineered Pig Organ Transplantation into Non-Human Primates - Project 2 - Coagulation and Adhesion Pathway Control to Protect Lung and Liver Xenografts
Genetically-Engineered Pig Organ Transplantation into Non-human Primates
Genetically-Engineered Pig Organ Transplantation into Non-human Primates - Administrative Supplement
Genetically-Engineered Pig Organ Transplantation into Non-human Primates - Core A - Production of Genetically Engineered Pigs
Genetically-Engineered Pig Organ Transplantation into Non-human Primates - Core B - Administrative
Genetically-Engineered Pig Organ Transplantation into Non-human Primates - Project 1 - Prolonging Life-Supported Pig Kidney and Heart Graft Survival in Baboons by Suppressing Inflammation
Genetically-engineered Pig Organ Transplantation into Non-human Primates - Ethical Aspects of Clinical Xenotransplantation: A National Survey of African Americans
Genetics and Virulence of Pneumococcal Capsular Types
Geographic Variability in Time from HIV Diagnosis to Viral Suppression in the Deep South: A Roadmap to Accelerated Treatment Initiation
Glucose Regulation of Bacterial Virulence in Diabetes and Hyperglycemia
HCMV miRNA Regulation of Secretion and Formation of the Viral Assembly Compartment
HCMV-Specific Memory T Cell Subsets and HCMV Breast Milk Transmission
HHSN27200001 Task Area 1 Task Order 1 - Sexually Transmitted Infections Clinical Trials Group (STI CTG)
HHSN27200002 Task Area 1 Task Order 2 Kick-off Meeting: Sexually Transmitted Infections Clinical Trials Group (STI CTG)
HHSN27200003 Task Area 2 Task Order 1 - Clinical Trial Implementation-DMID (STI CTG)
HHSN27200004 Task Area 2 Task Order 2 - Case Control Study Implementation (STI CTG)
HHSN27200005 Task Area 1 Task Order 5 - Protocol Development for "Clearance Time of Gonococcal Nucleic Acid by Nucleic Acid Amplification Testing" (STI CTG)
HHSN27200006 Task Area 1 Task Order 4 - Overall Administrative and Support Activities for the STI CTG to Include Procedures to Identify, Discuss, and Develop Scientific Concepts
HHSN27200007 Task Area 2 Task Order 5 - Clinical Trial Modification and Implementation - DMID Protocol #07-0012
HHSN27200008 Task Area 1 Task Order 8 - Protocol Development, Implementation and Analysis for A Randomized Single Blind Safety and Efficacy Study of TOL-463 Vaginal Gel or Insert in the Treatment of Vaginitis (BV and/or VVC)
HHSN27200009 Task Area 1 Task Order 7 - Overall Administrative and Support Activities for the STI CTG to Include Procedures to Identify, Discuss, and Develop Scientific Concepts
HHSN27200010 Task Area 1 Task Order 9 - Sexually Transmitted Infections Clinical Trials Group (STI CTG) TASK AREA 1 TASK ORDER 9 Protocol Development, Implementation and Analysis for Mycoplasma Genitalium Among Men with Urethritis Attending STD Clinics in the US: Assessing Burden, Risk Factors and Co-Infections
HHSN27200011 Task Area 1 Task Order 10 - Sexually Transmitted Infections Clinical Trials Group (STI CTG) TASK AREA 1 TASK ORDER 10 Protocol Development, Implementation and Analysis for Treatment of Gardnerella Vaginalis Vaginal Colonization with Amoxicillin
HHSN27200012 Task Area 1 Task Order 11 - Overall Admin and Support Activities for the STI CTG to Include Procedures to Identify, Discuss and Develop Scientific Concepts
HHSN27200013 TA2 TO7 Sexually Transmitted Infections Clinical Trials Group (STI CTG) - STI-CTG Task Area 2 Task Order 7 Protocol Development, Implementation and Analysis for a Randomized Controlled Trial of Azithromycin Versus Doxycycline for the Treatment of Rectal Chlamydia in Men who have Sex with Men
HHSN27200014 TA2 TO8 HHSN27220130012I Task Area 2 Task Order 8 - A Phase III Comparative Trial of Benzathine Penicillin G, 2.4 Million Units Administered as a Single Dose Versus Three Sucessive Weekly Doses for Treatment of Early Syphilis in Persons with and without HIV
HHSN27200015 TA1 TO13 STI CTG Task Area 1 Task Order 13: Protocol Development, Implementation and Analysis for Development and Validating an Easy to Administer Instrument to Define Penicillin (B-lactam) Allergy Status in STD Outpatients
HHSN27200016 TA1 TO 14 Task Area 1 Task Order 14: A Randomized, Placebo-Controlled Trial of TOL-463 for Suppression of Bacterial Vaginosis (BV)
HIV-1 Capsid Protein/Cyclophilin-A Complex: A Structural Study
HIV-1 Cryptic Epitopes: Implications for Vaccine Design
HLA *B Associated Genes and Memory B Cells in Patients with CVD
HLA Region and KIR Genomics in Common Variable Immune Deficiency
HO-1 and Granuloma Formation in TB Pleurisy
HTS for Bactericidal Inhibitors of M. Tuberculosis Copper Resistance Mechanisms
HTS for Copper-Activated Inhibitors Against MRSA
HTS for Copper-activated Inhibitors Against MRSA
HTS for Inhibitors of HIV-1 Latency Establishment
HTS for Inhibitors of HIV-1 Latency Establishment
HTS for Synergistic Activators of Latent HIV-1 Infection
Helper-Dependent CD8 T Cell Memory
Heme Oxygenase–1 and the Bioenergetic Threshold of Latent TB and HIV Co-Infection
Heme and Hemoglobin Utilization by Mycobacterium Tuberculosis
Heterogeneity in Cytokine Responses to HIV-1 Infection
Host Factors Required for Dengue and Yellow Fever Virus Amplification
Host Factors in Response to Therapeutic Monoclonal Antibodies and Vaccination
Host Genetic Epidemiology in HIV-1-Discordant African Couples and Other Cohorts
Host Immune Responses to Chlamydia trachomatis Candidate Vaccine Antigens and their Association with Clinical Correlates of Protective Immunity in Women
Hydrogen Peroxide and Capsule Production in Streptococcus Pneumoniae
Hydrogen Sulfide and Tuberculosis Disease
IL-21 and Immune Mediated Viral Control
Identification and Analysis of the Physiological Ligand for TLT2
Identification and Characterization of Effector Memory B Cell Populations That Dominate Memory Responses to Subsequent Influenza Infection and Vaccination
Identification of Drugs that Induce Terminal Transcriptional Silencing of Latent HIV-1 Infection
Identification of Pre-fusion Conformers of HCMV gB
IgM Fc Receptor in CLL
Immunobiology of Bacillus Anthracis Spore-Host Interactions
Immunoglobulin CDR-H3 and Neutralizing Antibodies to HIV
Immunologic Diseases and Basic Immunology
Immunologic Diseases and Basic Immunology
Immunologic Diseases and Basic Immunology
Immunologic Health in Aging PLWH
Immunologic Uniqueness of the Female Genital Tract in HIV Pathogenesis
Immunologic Uniqueness of the Female Genital Tract in HIV Pathogenesis - Admin Core
Immunologic Uniqueness of the Female Genital Tract in HIV Pathogenesis - Clinical Core B
Immunologic Uniqueness of the Female Genital Tract in HIV Pathogenesis - Project 1
Immunologic Uniqueness of the Female Genital Tract in HIV Pathogenesis - Project 2
Immunologic Uniqueness of the Female Genital Tract in HIV Pathogenesis - Project 3
Immunometabolism of M. Tuberculosis/HIV co-infection
Impact of Cross-Reactive CD8 T cells on HIV-1 Viral Control and Evolution
Impact of Menstrual Cycle on Antiretroviral Pharmacokinetics
Impact of a New Group 6 Serotype on Pneumococcal Vaccines
Importance Of Immune-Cell Lipid Signaling In Events Leading To Type 1 Diabetes
In Vitro Assessment for Antimicrobial Activity - B07 HHSN27200002 Comprehensive Virus Panel 2
In Vitro Assessment for Antimicrobial Activity - B09 HHSN27200003 Comprehensive Panel for Viruses
In Vitro Assessment for Antimicrobial Activity - B12 HHSN27200005 Comprehensive Panel for Viruses
In Vitro Assessments for Antimicrobial Activity
In Vitro Assessments for Antimicrobial Activity - B14 - HHSN27200004 Papillomavirus Assay
In Vitro Assessments for Antimicrobial Activity - B15 - HHSN27200006 In Vitro Assessment for Antimicrobial Activity
In Vitro Assessments for Antimicrobial Activity - B16 - HHSN27200007 Comprehensive Panel for Viruses
In Vitro Assessments of Antimicrobial Activity
In Vitro Assessments of Antimicrobial Activity - B01 Comprehensive Viral Screening Panel
Induction of Immunity in Human Genital Tract: Effect of Intranasal Immunization
Inhibition of Herpes Simplex Viruses Type 2 by Tenofovir
Innate Immunity and Viral Renal Allograft Injury
Innate Immunity and Viral Renal Allograft Injury
Integrating ENGagement and Adherence Goals upon Entry iENGAGE to Control HIV
Inter-CFAR (Center for AIDS Research) Collaborative Symposium on HIV Research in Women
Interaction of Sindbis Virus with Cellular Processes
Interleukin-21 Immune Mediated Control of HIV-1
Interplay Between the Mtb Electron Transport Chain and Carbon Metabolism
Intersection of Polyomavirus Infection and Host Cellular Responses
Kinomic Analysis of Host Cell Factors Controlling Latent HIV-1 Infection
Kinomic Analysis of Host Cell Factors Controlling Latent HIV-1 Infection
Liposomal Recombinant Vaccine and Caries Immunity
Mechanism of Alphavirus Packaging: Designing of Pseudoinfectious Viruses
Mechanism of Cell Surface Assembly Catalyzed by Sortases
Mechanism of Mycobacterium Tuberculosis Persistence
Mechanisms and Correlates of Immune Protection Against Genital Chlamydia in Humans
Mechanisms and Correlates of Immune Protection against Genital Chlamydia in Humans
Mechanisms of HBV Functional Cure During Tenofovir-based ART in HIV/HBV Coinfection
Mechanisms of Mycoplasmal Disease Pathogenesis
Mechanisms of Mycoplasmal Disease Pathogenesis
Mechanisms of Tissue and Organ Specific Human B Cell Immunity - IOFM Core: Infrastructure and Opportunity Fund Management Core
Mechanistic Role of ns2 Protein in Evasion of Innate Immune Response by Alphaviruses
Mechanistic Understanding of SH3 Domain-containing Protein Function in Alphavirus Replication
Metabolic Reprogramming of T Cell Energy Metabolism in Tuberculosis and HIV
Metabolic Reprogramming of T Cell Energy Metabolism in Tuberculosis and HIV
Microbial Interactions between Gardnerella, Prevotella, and Atopobium Prior to Incident Bacterial Vaginosis
Midcareer Mentoring Award for Patient-Oriented Research in Chlamydia Trachomatis Infection
Modeling FCRL6 Regulation and Function in Transgenic Mice
Molecular Analysis and Lineage Tracing of Influenza-Specific, Lung-Resident Memory B Cells
Molecular Analysis of HIV-1 Reverse Transcription
Molecular Characterization of T-beta's Role in Immunity
Molecular Characterization of the Role for T-bet and Bcl-6 in Immune Cell Metabolism and Differentiation
Molecular Epidemiology, Virulence, and Genomic Characterization of Ureaplasmas
Molecular Regulation of MS Susceptibility Genes
Molecular, Functional and Structural Analyses of Anti-PAD Antibodies in Rheumatoid Arthritis
Mucosal TGF-B/IL -6 Axis in the Regulation of T Cell Function
Multiple Functions of VEEV nsP3 in Virus Replication
Mycoplasma Polysaccharides and Control of Infection
Negative Regulatory Pathways in T Cell Quiescence and T Cell Response
Neutrophil-Mediated Immune Suppression as a Mechanism of HIV-1 Pathogenesis
New Generation of Efficient Vaccines Against Encephalitogenic Alphaviruses
New Influenza A Neuraminidase Inhibitors for Biodefense
Novel Mechanism of Cos Phage Size Redirection by Staphylococcal Pathogenicity Islands
Origin and Function of Double Negative T Cells in Lupus
Origin and Function of Double Negative T Cells in Lupus
Overcoming HIV-1 Transcriptional Latency in Unresponsive CD4 T Cells
Pathogenesis of Bacterial Vaginosis in Women Who Have Sex with Women
Pathogenic Autoantibodies with Specificity for Aberrant Glycoproteins: Assessment of a Therapeutic Target in an Autoimmune Disease
Physicians' Intentions to Administer HPV Vaccine
Pneumococcal Biofilm Formation is SpxB Dependent
Pneumococcal Capsule and Host Innate Immunity
Pneumococcal Conjugate Vaccines and Old Adults
Population Genetics Analysis Program: Immunity to Vaccines/Infections II
Post-Thymic T-Cell Functional Repetoire Heterogeneity
Protective Effects of Anti-BclA Antibodies in Bacillus Anthracis Infection
Protective Functions of Influenza-specific Lung-resident Memory B cells
PspA Binds Necroptotic Cells to Cause Disease and Transmit
PspA Mechanisms of Humoral Immunity, Functional Assays, and Optimal Vaccine Constructs
PspA: A Potential Pneumococcal Vaccine Component
Pulmonary Immunity to Pathogens in Neonates
RCT of Treatment of Male Partners of Women with Recurrent Bacterial Vaginosis
Randomized Controlled Trial of Treatment of Male Partners of Women with BV
Recent Advances in AIDS and HIV Research
Regulation of B Cell Clonal Diversity
Regulation of B Cell Clonal Diversity and Its Role in Disease
Regulation of B Cell Clonal Diversity and Its Role in Disease
Regulation of B Lymphocyte Survival and Differentiation by HSH2
Regulation of Positive-Stranded RNA Virus Infection by Host Factors of the Endomembrane System
Regulation of T Cell Activity During Chronic Infections
Regulation of T Cell Activity During Chronic Infections
Regulation of T Cell Activity during Chronic Infections
Regulation of T Cell Responses to Allergens and Environmental Microbes
Regulation of T Cell Responses to Allergens and Environmental Microbes
Regulation of T-Cell Dependent B Cell Responses to Influenza
Regulation of Tfh Cell Differentiation and Humoral Immunity
Regulation of Vibrio Biofilm Formation by H-NS Repression and Anti-Repression
Role of CCR1 in Cytokine Storm and Immunopathology after Influenza Infection
Role of Human Apolipoprotein E in Hepatitis B Virus Infection and Morphogenesis
Role of IG CDR-H3 in Responses to HIV Vaccines
Role of Immunogenetic Determinants on Human Genital Chlamydial Infection
Role of Immunoglobulin CDR-H3 in Heterosubtypic Immunity to Influenza Virus
Role of TGFBR3 in T-Cell Development and Immune Response
Role of VpreB in Immunoglobulin Antigen Binding Site Selection
Role of WhiB3 in M. tuberculosis Virulence
Roles of FCRL Molecules in Innate Immunity
Roles of FCRL Molecules in Innate Immunity
STAT4 Regulation of Effector CD4 T Cells and CNS Inflammation
STI & HIV 2019 World Congress, The Joint Meeting of the 23rd International Society for Sexually Transmitted Disease Research (ISSTDR) & 20th International Union Against Sexually Transmitted Infections (IUSTI)
Sexually Transmitted Infections Clinical Trials Group (STI CTG)
Sexually Transmitted Infections Clinical Trials Group (STI CTG)
Sexually Transmitted Infections Clinical Trials Group (STI CTG)
Sialylation Dependent Control of CD8 T cell Stemness during Chronic Viral Infection
Siderophore-Dependent Inhibitors of Mycobacterium Tuberculosis
Sindbis Nonstructural Protein nsP2: Interaction with Cellular Proteins
Single Round Infection Chikungunya Virus as a New Vaccine Candidate
Strain Dependent Structure and Function of the Influenza NS1 Protein
Streptococcus Pneumoniae Capsule Inhibitor
Structural Basis for Cellular Secretion and Uptake of HIV-1 Tat
Structural Basis for HIV-1 Gag Interactions with Cellular and Viral Constituents
Structural Basis for Mobilization of S. Aureus Pathogenicity Islands
Structural Basis for Mobilization of S. Aureus Pathogenicity Islands
Structural Basis for Pathogenicity Island Mobilization in S. aureus
Structural Basis of HIV-1 Gag Interactions with Cellular Constituents
Structural Basis of Vesicular Stomatitis Virus Transcription and Replication
Structural and Functional Studies on the Platelet Adherence Protein A of Streptoc
Structure Studies on Proteins that Modulate IL-10 Action
Structure and Design of Cytokine and Chemokine Binding Proteins
Structure and Function of the B. anthracis Exosporium
Studies of Paired Immunoglobulin-Like Receptors
Studies of Structure and Function of an Fc Receptor for IgM
Suppression of Pathogenic Autoantibodies in Lupus by Inhibition of AID
Survival Factors Regulating the HIV-Specific Cytotoxic T Lymphocyte Response
T011 HHSN27200010 TA1 TO9 Protocol Development, Implementation and Analysis for Mycoplasma Genitalium Among Men with Urethritis Attending STD Clinics in the US: Assessing Burden, Risk Factors and Co-Infections
T012 HHSN27200011 TA1 TO10 Protocol Development, Implementation and Analysis for Treatment of Gardnerella Vaginalis Vaginal Colonization with Amoxicillin
T013 HHSN27200012 TA1 TO11 Overall Admin and Support Activities for the STI CTG to Include Procedures to Identify, Discuss and Develop Scientific Concepts
T015 HHSN27200013 TA2 TO7 Protocol Development, Implementation and Analysis for a Randomized Controlled Trial of Azithromycin Versus Doxycycline for the Treatment of Rectal Chlamydia in Men who have Sex with Men
T016 HHSN27200014 TA2 TO8 A Phase III Comparative Trial of Benzathine Penicillin G, 2.4 Million Units Administered as a Single Dose Versus Three Sucessive Weekly Doses for Treatment of Early Syphilis in Persons with and without HIV
T017 HHSN27200015 TA1 TO13 Protocol Development, Implementation and Analysis for Development and Validating an Easy to Administer Instrument to Define Penicillin (B-lactam) Allergy Status in STD Outpatients
T018 HHSN27200016 TA1 TO14 A Randomized, Placebo-Controlled Trial of TOL-463 for Suppression of Bacterial Vaginosis (BV)
TLR7 and TLR9-Directed Plasma Cell Formation: Dissecting the Molecular Basis for their Differential Dependence on IFN-Induced Signals
Tandemly Repetitive Proteins in Mycoplasmas
Targeted Clinical Research to Address Select Viral Infections-A Phase II Randomized Six Weeks of Oral Valganciclovir Therapy in CMV Infants with Hearing Loss
Targeted Clinical Research to Address Select Viral Infections-An Adaptive Pharmacokinetic, Pharmacodynamic, Concentration Response Investigation of CMX-001 in the Infants with Neonatal Herpes (HSV) Followed by Randomized Assessment
Targeted Clinical Research to Address Select Viral Infections-An Adaptive, Sequential Study Evaluation Prevention of Neonatal Herpes Simplex Virus Disease: Detection of Maternal Herpes Simplex Virus Shedding at Delivery
Targeted Clinical Research to Address Select Viral Infections-Pharmacokinetic, Pharmacodynamic and Resistance Evaluation of Intravenous Ganciclovir in Premature Infants
Targeted Clinical Research to Address Select Viral Infections-Safety, Tolerability and Pharmacokinetic Properties of CMX001 in Renal Transplant Recipients with BK Viremia.
Targeting MMP9 to Improve Outcomes in Serious Influenza Infections
Tet1 Activity and Function in Helper T Cells
The Impact of HIV Adaptation to CD8 T Cells on Infection and Viral Control
The Influence of Anti-N-Acetyl-D-Glucosamine B Cells on Type One Diabetes in Mice
The Molecular Basis of VEEV Pathogenesis
The Necrosis-Inducing Toxin of Mycobacterium Tuberculosis
The Pre-BCR CDR-H3 Sensing Site and H Chain Selection
The Regulation of T Cell Exhaustion by Adhesion Molecules
The Role of CD5 in B-Cell Development and Autoimmunity
The Role of IL-10 Secreting MZ B Cells in Response to a Bacterial Challenge
The Role of IL-17 Producing T Lymphocytes in Allergic Contact Dermatitis
The Role of Immunoglobulin CDRH3 in Autoimmune Disease
The Role of PcpA in the Mechanism of Virulence and Protective Immunity
The Role of wcjE Disruption in Pneumococcal Serotype 11A Humoral Escape
The Roles of LPS-Binding Protein Vascular Peroxidase-1 in Innate Immunity
The UAB Infectious Diseases Training Grant
The UAB STI CRC - DiSCIS Administrative Core
The UAB STI CRC - DiSCIS Biostatistics & Bioinformatics Core
The UAB STI CRC - DiSCIS Clinical Core
The UAB STI CRC - DiSCIS Laboratory Core
The UAB STI CRC - Project 1: Determining the Origins of NGU in Men Through Evaluation of Sexual Partnerships
The UAB STI CRC - Project 2: Strain Diversity among Gardnerella: Association with Progression to BV
The UAB STI CRC - Project 3: Effect of Trichomonas and BV on Chlamydia Concordance and Treatment Outcomes
The UAB Sexually Transmitted Infections Cooperative Research Centers (STI CRC)
The UAB Sexually Transmitted Infections Cooperative Research Centers (STI CRC)
The UAB Sexually Transmitted Infections Cooperative Research Centers (STI CRC) - CRC Project 1
The UAB Sexually Transmitted Infections Cooperative Research Centers (STI CRC) - Core A-Administrative Core
The UAB Sexually Transmitted Infections Cooperative Research Centers (STI CRC) - Core B-Clinical Core
The V(D)J Recombination Reaction and ITS impact on Lymphocyte Development
Thiol Mediated Redox Homeostasis in Haemophilus Influenzae Biofilms
Tissue and Organ Specific Human B Cell Immunity
Tissue and Organ Specific Human B Cell Immunity - Project 1: Development and Maintenance of Human Glycan and Phospholipid Antibody Repertoires
Tissue and Organ Specific Human B Cell Immunity - Project 2: Characterization of Virus-Specific Human B Cell Subsets in Lymphoid and Non-Lymphoid Tissues
Tissue and Organ Specific Human B Cell Immunity - Core A: Administrative Core
Tissue and Organ Specific Human B Cell Immunity - Core B: Human Tissue Collection, Processing and Repository Core
Tissue and Organ Specific Human B Cell Immunity - Core C: B Cell Receptor Repertoire, Cloning and Expression Core
Tissue and Organ Specific Human B Cell Immunity - Core D: Data Analytics and Bioinformatics Core
Trafficking Mechanism of Gram-Positive Bacterial Moonlighting Proteins
Transcription and Replication in Nonsegmented Negative-Strand RNA Viruses
Transcriptional Regulation of T Cell Quiescence and Activation
Translational Control of Gene Expression in Positive Stranded RNA Viruses
UAB Autoimmunity Center for Excellence
UAB Autoimmunity Center for Excellence: Core A - Administrative Core
UAB Autoimmunity Center for Excellence: Core B - Immunomodulatory Studies Core
UAB Autoimmunity Center for Excellence: Project 3 - Tolerance Induction to Restructure Immune Responses
UAB Autoimmunity Center for Excellence: Project 4 - Development and Maintenance of Intestinal Regulatory T Cells
UAB Center for AIDS Research
UAB Center for AIDS Research
UAB Center for AIDS Research (CFAR)
UAB Center for AIDS Research (CFAR) - A Dynamic COVID-19 Community-Engaged Testing Strategy in Alabama (COVID COMET AL)
UAB Center for AIDS Research (CFAR) - CFAR Supplement - Telemedicine to Integrate Substance Use and HIV Care Delivery for Persons who Inject Drugs in Alabama (TISH Study)
UAB Center for AIDS Research (CFAR) - EHE Implementation Science Consultation Hub
UAB Center for AIDS Research (CFAR) - Mobile Testing to Increase HIV-testing Uptake in Rural Alabama: A Pilot Implementation Project (MOBILISE)
UAB Center for AIDS Research (CFAR) - ProTECT: PrEP Optimization Through Enhanced Continuum Tracking (Elopre)
UAB Center for AIDS Research - Administration Core
UAB Center for AIDS Research - Administrative Core
UAB Center for AIDS Research - Administrative Core
UAB Center for AIDS Research - Administrative Supplement
UAB Center for AIDS Research - Bansal
UAB Center for AIDS Research - Biostatistics and Epidemioloogy
UAB Center for AIDS Research - Biostats Core D
UAB Center for AIDS Research - CFAR Administrative Supplement - Adipocyte-derived Exosomes and Mitochondrial Signaling in Immune Activation of Obese HIV+ Asthmatics
UAB Center for AIDS Research - CFAR Administrative Supplement - Effect of cART Therapy on Placental Morphology and Pregnancy Outcomes in HIV Infected Women
UAB Center for AIDS Research - CFAR Administrative Supplement - Inter-CFAR Faith and Spirituality Research Collaborative Meeting
UAB Center for AIDS Research - CFAR Administrative Supplement - Inter-CFAR HIV in the Southeast Working Group Meeting
UAB Center for AIDS Research - CFAR Administrative Supplement - Promoting PrEP use among African-American AGYW in the Deep South at-risk for HIV: Provider and Client Perspectives
UAB Center for AIDS Research - CFAR Supplement - Continuum of Care in Hospitalized Patients with Opioid Use Disorder (OUD) and Infectious Complications of Drug Use (CHOICE)
UAB Center for AIDS Research - Care Cascade and Discharge Outcomes of Hospitalized HIV + Aambians
UAB Center for AIDS Research - Clinical Core
UAB Center for AIDS Research - Clinical Core C
UAB Center for AIDS Research - Community Deep South Treatment Cascade Integration and Enhancement
UAB Center for AIDS Research - Core B - Developmental Core
UAB Center for AIDS Research - Core C - Clinical Core
UAB Center for AIDS Research - Core H - Basic Research Core
UAB Center for AIDS Research - Core J - Behavioral and Community Sciences Core
UAB Center for AIDS Research - DNA Sequencing
UAB Center for AIDS Research - DNA Sequencing
UAB Center for AIDS Research - DNA Training
UAB Center for AIDS Research - Development Core
UAB Center for AIDS Research - Development Core
UAB Center for AIDS Research - Developmental Core B
UAB Center for AIDS Research - Diversity Supplement (HEATH)
UAB Center for AIDS Research - Diversity Supplement (SHRESTHA)
UAB Center for AIDS Research - Flow Cytometry
UAB Center for AIDS Research - Flow Cytometry Core H
UAB Center for AIDS Research - Genomics Core G
UAB Center for AIDS Research - International Core
UAB Center for AIDS Research - International Core
UAB Center for AIDS Research - Lipidomic Profiling in HIV Patients Newly Initiating Antiretroviral Treatment
UAB Center for AIDS Research - Malignancy
UAB Center for AIDS Research - Matthews
UAB Center for AIDS Research - Prevention Behavior Sciences
UAB Center for AIDS Research - The Detrimental Nexus of HCV and HIV Infection on Bioenergetics and Immune Function
UAB Center for AIDS Research - The Microbiome, Diet, and Incomplete CD4 Recovery on Antiretroviral Therapy
UAB Center for AIDS Research - The Role of HIV-Infection and Antiretroviral Therapy Related Mitochondrial Toxicity in Accelerated Aging
UAB Center for AIDS Research - UAB CFAR - Administrative Supplement Announcement Multidisciplinary Research Project from a Scientific Working Group (SWG) -Finding Respect and Ending Stigma around HIV in Healthcare Settings in the United States
UAB Center for AIDS Research - UAB CFAR - Administrative Supplement Establishment of a HIV-1 Transplant Tissue
UAB Center for AIDS Research - UAB CFAR- Administrative Supplement CFAR HIV in Women Symposium
UAB Center for AIDS Research - UAB CFAR- Administrative Supplement-Clinical Core Equipment
UAB Center for AIDS Research - Using Big Data to Estimate Undiagnosed HIV Infection and Inform Testing Interventions in Alabama
UAB Center for AIDS Research - Virology
UAB Center for AIDS Research - Virology Core K
UAB Center for AIDS Research -SWG Core - Ending HIV in Alabama SWG
UAB Center for AIDS Research-Administrative Supplement-Shedding New Light on the Assessment of Retention in Care for the People living with HIV in the Deep South: A Novel Approach Using Longitudinal Datasets and Data Linkage
UAB Infectious Diseases Training Grant
UAB-MISS WIHS Cohort
UAB-MISS WIHS Cohort
Underlying Mechanism of ApoE in HCV Infection and Assembly
Unsolicited R24 CFAR Network of Clinical Systems (CNICS)
Unsolicited R24 for the CFAR-Network of Integrated Clinical Sciences, CNICS
Unsolicited R24 for the CFAR-Network of Integrated Clinical Sciences, CNICS
VPO1 Protects From Endotoxin-Mediated Inflammation and Septic Shock
Vaccine Potential of the Proline-Rich Domain of Pneumococcal Surface Protein A
Vaginal Dendritic Cells Selectively Transmit HIV-1 Founder Virus
Viral Adaptation to CD4 T Cell Responses and the Impact on HIV Immunity
Viral and Cellular Determinants of HCV Assembly
Viremia Copy-Years: Measuring the Effect of Cumulative HIV Burden on Outcomes
Virus-Induced Cell Fate Decisions in Anti-Viral Immunity
Virus-Induced Cell Fate Decisions in Anti-Viral Immunity - Core A - Administrative and Biostatistics Core
Virus-Induced Cell Fate Decisions in Anti-Viral Immunity - Core B - Viral Stocks and Reagents
Virus-Induced Cell Fate Decisions in Anti-Viral Immunity - Core C - Human Immunology
Virus-Induced Cell Fate Decisions in Anti-Viral Immunity - Project 1 - Control of Anti-Viral Tfh Responses Via IL-2 Signaling and Availability
Virus-Induced Cell Fate Decisions in Anti-Viral Immunity - Project 2 - Regulation of Anti-Viral CD8+ T Cell Responses Via Adhesion Molecules
Virus-Induced Cell Fate Decisions in Anti-Viral Immunity - Project 3 - Control of Anti-Viral B Cell Responses by IFNy T-bet and Eomes
Virus-Induced Cell Fate Decisions in Anti-Viral Immunity - Project 4 - Natural and Induced IgM as Regulators of Antiviral Humoral Immunity
Virus-induced Cell Fate Decisions in Anti-Viral Immunity - Administrative Supplement
gM/gN and Envelopment of HCMV
